Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 The occurrence rate of advanced collapse in the teriparatide and alendronate groups at the end of follow-up and the final collapse progression in the teriparatide and alendronate groups

From: Efficacy of teriparatide in the treatment of nontraumatic osteonecrosis of the femoral head: a retrospective comparative study with alendronate

  Teriparatide group Alendronate group p value
Advanced collapse 6/18 (33.3%) 13/22 (59.1%) 0.105
Final collapse progression 0.67 mm (0.00-3.61 mm) 1.24 mm (0.00-3.22 mm) 0.049
  1. ‡Significant